Alexium International Group Limited (E7T) - Total Liabilities
Based on the latest financial reports, Alexium International Group Limited (E7T) has total liabilities worth €3.28 Million EUR (≈ $3.83 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Alexium International Group Limited (E7T) cash conversion ratio to assess how effectively this company generates cash.
Alexium International Group Limited - Total Liabilities Trend (2013–2025)
This chart illustrates how Alexium International Group Limited's total liabilities have evolved over time, based on quarterly financial data. Check Alexium International Group Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
Alexium International Group Limited Competitors by Total Liabilities
The table below lists competitors of Alexium International Group Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Monarca Minerals Inc
V:MMN
|
Canada | CA$6.00 Million |
|
PSYCHED WELLNESS LTD
F:5U9
|
Germany | €644.82K |
|
Labrador Technologies Inc
V:LTX
|
Canada | CA$1.24 Million |
|
Stayble Therapeutics AB
ST:STABL
|
Sweden | Skr1.70 Million |
|
Dotdigital Group Plc
LSE:DOTD
|
UK | GBX38.86 Million |
|
NTR Holding A/S
CO:NTR-B
|
Denmark | Dkr600.00K |
|
PREMIA FINANCE O.N.
F:81U
|
Germany | €1.78 Million |
|
Northern Venture Trust
LSE:NVT
|
UK | GBX188.00K |
Liability Composition Analysis (2013–2025)
This chart breaks down Alexium International Group Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Alexium International Group Limited market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -8.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alexium International Group Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alexium International Group Limited (2013–2025)
The table below shows the annual total liabilities of Alexium International Group Limited from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €3.28 Million ≈ $3.83 Million |
+70.31% |
| 2024-06-30 | €1.93 Million ≈ $2.25 Million |
-69.75% |
| 2023-06-30 | €6.36 Million ≈ $7.44 Million |
+31.27% |
| 2022-06-30 | €4.85 Million ≈ $5.67 Million |
-23.07% |
| 2021-06-30 | €6.30 Million ≈ $7.37 Million |
-30.72% |
| 2020-06-30 | €9.10 Million ≈ $10.63 Million |
-30.47% |
| 2019-06-30 | €13.08 Million ≈ $15.29 Million |
+13.82% |
| 2018-06-30 | €11.49 Million ≈ $13.44 Million |
+21.86% |
| 2017-06-30 | €9.43 Million ≈ $11.03 Million |
+226.04% |
| 2016-06-30 | €2.89 Million ≈ $3.38 Million |
+256.33% |
| 2015-06-30 | €811.77K ≈ $949.05K |
-60.16% |
| 2014-06-30 | €2.04 Million ≈ $2.38 Million |
-1.41% |
| 2013-06-30 | €2.07 Million ≈ $2.42 Million |
-- |
About Alexium International Group Limited
Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; Eclipsys, a perpetual cooling technology that enhance the… Read more